Efficacy, pharmacodynamics, and safety of VX‐702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double‐blind, placebo‐controlled clinical studies
Year: 2009
Type: article
Study design: Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.24485
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1977683934
